130 related articles for article (PubMed ID: 6216459)
1. Biokinetics of bone tracers by means of deconvolution analysis--comparison of 99mTc MDP, 99mTc DPD and 99mTc EHDP.
Knop J; Stritzke P; Kröger E; Schneider C; Wasmus G
Nuklearmedizin; 1982 Aug; 21(4):145-9. PubMed ID: 6216459
[TBL] [Abstract][Full Text] [Related]
2. Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.
Subramanian G; McAfee JG; Blair RJ; Kallfelz FA; Thomas FD
J Nucl Med; 1975 Aug; 16(8):744-55. PubMed ID: 170385
[TBL] [Abstract][Full Text] [Related]
3. The visualization of femoral vessels in delayed bone scans--a sign of arteriosclerosis? A comparison of 99mTc-MDP and 99mTc-DPD.
Lantto T; Järvi K; Toivio I; Vähätalo S; Vorne M
Eur J Nucl Med; 1989; 15(5):265-8. PubMed ID: 2759127
[TBL] [Abstract][Full Text] [Related]
4. 99Tcm-MDP and 99Tcm-DPD in pathologic bone lesions. A visual and quantitative comparison.
Lantto T; Vorne M; Mokka R; Vähätalo S
Acta Radiol; 1987; 28(5):631-3. PubMed ID: 2960361
[TBL] [Abstract][Full Text] [Related]
5. Duration of etidronate effect demonstrated by serial bone scintigraphy.
Sandler ED; Parisi MT; Hattner RS
J Nucl Med; 1991 Sep; 32(9):1782-4. PubMed ID: 1908891
[TBL] [Abstract][Full Text] [Related]
6. The distribution of 99mTc-EHDP in the tissues of the dog and its application in the assessment of fracture healing.
Hughes S
Ann R Coll Surg Engl; 1977 Jul; 59(4):322-7. PubMed ID: 879636
[TBL] [Abstract][Full Text] [Related]
7. The scintigraphy of sacroiliac joints. A comparison of 99mTc-DPD and 99mTc-MDP.
Lantto T
Eur J Nucl Med; 1990; 16(8-10):677-81. PubMed ID: 2143475
[TBL] [Abstract][Full Text] [Related]
8. Bone extraction and blood clearance of diphosphonate in the dog.
Hughes SP; Davies DR; Bassingthwaighte JB; Knox FG; Kelly PJ
Am J Physiol; 1977 Mar; 232(3):H341-7. PubMed ID: 402827
[TBL] [Abstract][Full Text] [Related]
9. Technetium-99m complexes of dimethylaminomethylene diphosphonate (DMAD)--II. Biological distributions of 99mTc-DMAD components isolated by anion exchange HPLC.
Holland ME; Bugaj J; Heineman WR; Deutsch E
Int J Rad Appl Instrum B; 1989; 16(3):313-7. PubMed ID: 2497091
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting uptake and retention of technetium-99m-diphosphonate and 99m-pertechnetate in osseous, connective and soft tissues.
Francis MD; Slough CL; Tofe AJ
Calcif Tissue Res; 1976 Jun; 20(3):303-11. PubMed ID: 182328
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of the distribution of 99mTc-labelled ethylene hydroxy diphosphonate in young rats.
Rohlin M; Nosslin B
Eur J Nucl Med; 1977 Jun; 2(2):113-5. PubMed ID: 891555
[TBL] [Abstract][Full Text] [Related]
12. [Bone metabolism in thalassemic children with multiple transfusions. Compartmental analysis of 99mTc-Sn-MDP kinetics].
Mele M; De Mattia D; D'Addabbo A; Schettini F; Lauriero F; Rubini G
Radiol Med; 1989 Nov; 78(5):455-60. PubMed ID: 2608933
[TBL] [Abstract][Full Text] [Related]
13. [A comparison of osteotropic radiopharmaceuticals. II. Plasma clearance of 18F and 99mTc-EHDP (author's transl)].
Creutzig H
Rofo; 1975 Oct; 123(4):313-8. PubMed ID: 129388
[TBL] [Abstract][Full Text] [Related]
14. Skeletal nonvisualization in a bone scan secondary to intravenous etidronate therapy.
Hommeyer SH; Varney DM; Eary JF
J Nucl Med; 1992 May; 33(5):748-50. PubMed ID: 1569485
[TBL] [Abstract][Full Text] [Related]
15. A study of the relationship between chemical structure and bone localization of Tc-99m diphosphonic acids: concise communication.
Wang TS; Mojdehi GE; Fawwaz RA; Johnson PM
J Nucl Med; 1979 Oct; 20(10):1066-70. PubMed ID: 536757
[TBL] [Abstract][Full Text] [Related]
16. Skeletal uptake of 99mTc-diphosphonate in relation to local bone blood flow.
Siegel BA; Donovan RL; Alderson PO; Mack GR
Radiology; 1976 Jul; 120(1):121-3. PubMed ID: 935433
[TBL] [Abstract][Full Text] [Related]
17. The effect of DMSO treatment on the composition of 99mTc(Sn)EHDP.
de Groot GJ; Das HA; de Ligny CL
Int J Rad Appl Instrum A; 1986; 37(6):487-90. PubMed ID: 3019948
[TBL] [Abstract][Full Text] [Related]
18. Complexing of reduced technetium and tin(II) by chelating phosphate compounds. II. In vitro stability of pyrophosphate and ethane-1, hydroxy-1, diphosphonate (EHDP) complexes.
Schümichen C; Hohloch M; Hoffmann G
Nuklearmedizin; 1979 May; 18(2):105-9. PubMed ID: 38437
[TBL] [Abstract][Full Text] [Related]
19. [Study on tumor affinity of technetium-99m-labeled radiopharmaceuticals. (2) 99mTc-Sn-diphosphonate (99mTc-EHDP), 99mTc-Sn-dimercaptosuccinic acid (99mTc-DMSA), and 99mTc-Sn-diethyl stilbestrol diphosphate (99mTc-DSDP)].
Ito K; Kobayashi S; Hisada K; Tonami N; Ando A
Radioisotopes; 1976 Oct; 25(10):622-9. PubMed ID: 1037404
[TBL] [Abstract][Full Text] [Related]
20. Determination of lesion to normal bone uptake ratios of skeletal radiopharmaceuticals by QARG (quantitative autoradiography).
Ghiron J; Volkert WA; Garlich J; Holmes RA
Int J Rad Appl Instrum B; 1991; 18(2):235-40. PubMed ID: 2026500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]